(3aS,8aR)-2-(5-(Trifluoromethyl)pyridin-2-yl)-3a,8a-dihydro-8H-indeno[1,2-d]oxazole, 95%, 1g

2-Acetamidothiazole>98.0%(GC)25g

Ethyl 2-(methylamino)pyridine-3-carboxylate, 95%, 1g

UPADACITINIB, 97%, 10mg

(S)-2,2,2-Trifluoro-1-(2-fluorophenyl)ethan-1-amine hydrochloride, 95%, 1g

1-Bromo-3,5-diiodobenzene>98.0%(GC)5g

(7ALPHA,17BETA)-7-(9-((4,4,5,5,5-PENTAFLUOROPENTYL)THIO)NONYL)-ESTRA-1,3,5(10)-TRIENE-3,17-DIOL 17-ACETATE, 95%, 250mg

Cytosine, min. 99%, for biochemistry, 25 g, plastic packaging.

(3S,6S,9S,12S,15S)-METHYL 3-BENZYL-1-(4-(TERT-BUTYL)PHENYL)-12-(4-(DIETHYLAMINO)BUTYL)-15-(HYDROXYMETHYL)-9-ISOBUTYL-6-METHYL-1,4,7,10,13-PENTAOXO-2,5,8,11,14-PENTAAZAHEXADECAN-16-OATE, 95%, 5mg

(R)-2-Amino-2-(2,3-dihydro-1H-inden-2-yl)acetic acid, 97%, 250mg

Methyl 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)nicotinate, 95.0%, 1g

(Z)-(1-benzylpyridin-1-ium-4-yl)(5,6-dimethoxy-1-oxo-1H-inden-2(3H)-ylidene)methanolate, potassium salt (hydrobromide), 97%, 250mg

Methyl2-(benzyloxycarbonylamino)-2-(oxetan-3-yl)acetate, 98%, 100g